Cargando…
Nano-curcumin’s suppression of breast cancer cells (MCF7) through the inhibition of cyclinD1 expression
BACKGROUND: Breast cancer is the leading cause of cancer worldwide. The high expenses associated with chemotherapy as well as its side effects make the management of breast cancer a daunting challenge. The most common overexpressed gene in breast cancer is cyclinD1, which induces cell proliferation....
Autores principales: | Hosseini, Sare, Chamani, Jamshidkhan, Hadipanah, Mohammad Reza, Ebadpour, Negar, Hojjati, Amir Sajjad, Mohammadzadeh, Mohammad Hasan, Rahimi, Hamid Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420787/ https://www.ncbi.nlm.nih.gov/pubmed/30936742 http://dx.doi.org/10.2147/BCTT.S195800 |
Ejemplares similares
-
The effect of nanomicelle curcumin, sorafenib, and combination of the two on the cyclin D1 gene expression of the hepatocellular carcinoma cell line (HUH7)
por: Hosseini, Sare, et al.
Publicado: (2019) -
CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cells
por: Sun, Yuan, et al.
Publicado: (2012) -
Determination of LMF Binding Site on a HSA-PPIX Complex in the Presence of Human Holo Transferrin from the Viewpoint of Drug Loading on Proteins
por: Sattar, Zohreh, et al.
Publicado: (2014) -
CyclinD1, a prominent prognostic marker for endometrial diseases
por: Liang, Shuo, et al.
Publicado: (2013) -
Novel delivery system for natural products: Nano-curcumin formulations
por: Rahimi, Hamid Reza, et al.
Publicado: (2016)